Novel avilamycin derivatives with improved polarity generated by targeted gene disruption

Gabriele Weitnauer, Gerd Hauser, Carsten Hofmann, Ulrike Linder, Raija Boll, Klaus Pelz, Steffen J. Glaser, Andreas Bechthold

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Abstract

The oligosaccharide antibiotics avilamycin A and C are produced by Streptomyces viridochromogenes Tü57. Both consist of a heptasaccharide chain, which is attached to a polyketide-derived dichloroisoeverninic acid moiety. They show excellent antibiotic activity against Gram-positive bacteria. Both molecules are modified by O-methylation at different positions, which contributes to poor water solubility and difficulties in galenical drug development. In order to generate novel avilamycin derivatives with improved polarity and improved pharmacokinetic properties, we generated a series of mutants with one, two, or three mutated methyltransferase genes. Based on the structure of the novel avilamycin derivatives, the exact function of three methyltransferases, AviG2, AviG5, and AviG6, involved in avilamycin biosynthesis could be assigned.

Original languageEnglish
Pages (from-to)1403-1411
Number of pages9
JournalChemistry and Biology
Volume11
Issue number10
DOIs
StatePublished - Oct 2004

Fingerprint

Dive into the research topics of 'Novel avilamycin derivatives with improved polarity generated by targeted gene disruption'. Together they form a unique fingerprint.

Cite this